Stockscreener 앱 받기
15.96
5.14%
0.78
Seres Therapeutics Inc 주식(MCRB)의 최신 뉴스
Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50 Day Moving Average – Time to Sell? - Defense World
Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50 Day Moving AverageTime to Sell? - MarketBeat
Aug Retail: Is Pro Dex Inc benefiting from interest rate changesWeekly Market Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Chart Watch: Can Seres Therapeutics Inc weather a recessionEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Whats next for Seres Therapeutics Inc stockMarket Sentiment Summary & Smart Allocation Stock Reports - baoquankhu1.vn
Aug Momentum: Will Seres Therapeutics Inc. stock deliver better than expected guidance2025 Top Gainers & Capital Efficient Trading Techniques - Bộ Nội Vụ
Will Seres Therapeutics Inc. stock deliver better than expected guidanceWeekly Market Summary & Free High Accuracy Swing Entry Alerts - Улправда
Seres Therapeutics, Inc.Common Stock (NQ: MCRB - FinancialContent
Published on: 2026-01-13 00:08:06 - ulpravda.ru
Seres Therapeutics publishes new insights on VOWST mechanism By Investing.com - Investing.com Nigeria
Why Seres Therapeutics Inc. stock is in analyst buy zone2026 world cup usa national team final playmakers low block defense expert forecast expert opinion - Улправда
Seres Therapeutics expands board, appoints new director - MSN
Seres Therapeutics publishes new insights on VOWST mechanism - Investing.com
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy - GlobeNewswire
Seres Therapeutics Q1 2025 Earnings Preview - MSN
Why Seres Therapeutics Inc. stock is rated strong buyInterest Rate Changes & Minimal Risk High Reward - bollywoodhelpline.com
Seres Therapeutics (NASDAQ:MCRB) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround - The Globe and Mail
How Seres Therapeutics Inc. stock responds to policy changesGlobal Markets & Verified Entry Point Detection - Улправда
The Great Biotech Re-Shoring: Seres Therapeutics and the New Commodity-Driven Era - FinancialContent
Can Seres Therapeutics Inc. (1S90) stock stage a strong rebound this quarterMarket Volume Report & Fast Gain Swing Alerts - DonanımHaber
Why analysts remain bullish on Seres Therapeutics Inc. stockRate Cut & Daily Profit Focused Stock Screening - DonanımHaber
Is Seres Therapeutics Inc. stock affected by interest rate hikesCPI Data & Weekly Return Optimization Alerts - Улправда
Will Seres Therapeutics Inc. stock gain from government policiesJuly 2025 Market Mood & Weekly Top Stock Performers List - Улправда
Seres Therapeutics Cuts Costs to Extend Cash Runway - MSN
Head-To-Head Contrast: Castle Biosciences (NASDAQ:CSTL) versus Seres Therapeutics (NASDAQ:MCRB) - Defense World
North America Human Microbiome Market Size & Growth Forecast to 2031 - MarketsandMarkets
Guidance Update: How Seres Therapeutics Inc 1S90 stock compares with market leaders2025 Biggest Moves & Long-Term Growth Stock Strategies - moha.gov.vn
Published on: 2025-12-13 20:57:20 - moha.gov.vn
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Above 50 Day Moving AverageHere's What Happened - MarketBeat
Seres Therapeutics (MCRB) price target increased by 31.25% to 21.42 - MSN
Seres Therapeutics, Inc. (MCRB) 5.04% in After-hours: What’s Driving the Move? - Stocks Telegraph
Seres Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving Average – Here’s What Happened - Defense World
Seres Therapeutics (MCRB) Price Target Increased by 31.25% to 21.42 - Nasdaq
What risks investors should watch in Seres Therapeutics Inc. stockQuarterly Growth Report & Accurate Intraday Trading Signals - Newser
Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving AverageHere's What Happened - MarketBeat
Will Seres Therapeutics Inc. (1S90) stock outperform foreign stocksWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Will Seres Therapeutics Inc. (1S90) stock beat value stocks2025 Year in Review & Verified Chart Pattern Signals - Newser
What market sentiment indicators show for Seres Therapeutics Inc. (1S90) stock2025 Institutional Moves & Free Daily Entry Point Trade Alerts - Newser
Is Seres Therapeutics Inc. stock dividend yield sustainablePortfolio Update Report & Growth Oriented Trade Recommendations - Newser
Is Seres Therapeutics Inc. stock positioned for long term growth2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Seres Therapeutics (MCRB) Stock Analysis Report | Financials & Insights - Benzinga
Seres Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Volatility Watch: Why Seres Therapeutics Inc. stock is rated strong buyJuly 2025 Review & High Accuracy Trade Alerts - Bộ Nội Vụ
4.73%
0.92%
자본화:
|
볼륨(24시간):